Sumalpong, Tata Eldie E.
HRN: 25-69-96 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/16/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/16/2024
08/23/2024
IV
300mg
Q8h
Nonhealing Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes